Hebei Kexing Pharmaceutical Co., Ltd.

Products

Home > Products > Animal Antibacterial Drugs > Florfenicol > Florfenicol Injection 30% Veterinary

Florfenicol Injection 30% Veterinary

Payment Type:
L/C,T/T,D/P
Incoterm:
FOB,CFR,CIF
Min. Order:
5000 Bag/Bags
Transportation:
Ocean
Share:
  • Product Description
Overview
Product Attributes

Model No.10% 30%

BrandHEXIN

VarietiesGeneral Disease Prevention Medicine

ComponentAnimal

TypeThe Fifth Class

Pharmacodynamic Influential FactorsAnimal Species

Storage MethodPrevent ThrowIing Expired Veterinary Drugs

Supply Ability & Additional Information

Packaging10ml ampoule and 30ml,50ml,100ml,250ml,500ml bottle.

Productivity20000 bottles per day

TransportationOcean

Place of OriginHebei, China (Mainland)

Supply Ability20000 boxes per day

CertificateGMP ISO

HS Code3004909099

Payment TypeL/C,T/T,D/P

IncotermFOB,CFR,CIF

Packaging & Delivery
Selling Units:
Bag/Bags
Package Type:
10ml ampoule and 30ml,50ml,100ml,250ml,500ml bottle.
                                              Florfenicol Injection 30% Veterinary Medicine

Florfenicol Injection is a synthetic broad-spectrum antibiotic effective against most Gram-positive and Gram-negative bacteria isolated from domestic animals. Florfenicol 30% Injection Veterinary acts by inhibiting protein synthesis at the ribosomal level and is bacteriostatic. Laboratory tests have shown that florfenicol is active against the most commonly isolated bacterial pathogens involved in bovine respiratory disease which include Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Arcanobacterium pyogenes, and against the bacterial pathogens most commonly isolated in Respiratory Diseases in pigs, including Actinobacillus pleuropneumoniae and Pasteurella multocida.

 

COMPOSITION:

Contains per ml.:

Enrofloxacin----... 300 mg.

Excipients ad ----.1 ml.

DESCRIPTION:

Florfenicol 30% Injection veterintry is a synthetic broad-spectrum antibiotic effective against most Gram-positive and Gram-negative bacteria isolated from domestic animals. Florfenicol acts by inhibiting protein synthesis at the ribosomal level and is bacteriostatic. Laboratory tests have shown that florfenicol is active against the most commonly isolated bacterial pathogens involved in bovine respiratory disease which include Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Arcanobacterium pyogenes, and against the bacterial pathogens most commonly isolated in respiratory diseases in pigs, including Actinobacillus pleuropneumoniae and Pasteurella multocida.

INDICATIONS:

Florfenicol 30% Injection veterintry Indicated for preventive and therapeutic treatment of respiratory tract infections in cattle due to Mannheimia haemolytica, Pasteurella multocida and Histophilus somni. The presence of the disease in the herd should be established before preventive treatment. It is additionally indicated for treatment of acute outbreaks of respiratory disease in pigs caused by strains of Actinobacillus pleuropneumoniae and Pasteurella multocida susceptible to florfenicol.

DOSAGE AND ADMINISTRATION:

For subcutaneous or intramuscular injection.

 Florfenicol 30% Injection veterintry Antibiotics for Cattle:

Treatment (IM): 1 ml per 15 kg body weight, twice at a 48-h interval.

Treatment (SC): 2 ml per 15 kg body weight, administered once.

Prevention (SC): 2 ml per 15 kg body weight, administered once.

The injection should only be given in the neck. The dose should not exceed 10 ml per injection site.

Swine: 1 ml per 20 kg body weight (IM), twice at a 48-hour interval.

Florfenicol 30% Injection veterintry should only be given in the neck. The dose should not exceed 3 ml per injection site.

It is recommended to treat animals in the early stages of disease and to evaluate the response to treatment within 48 hours after the second injection. If clinical signs of respiratory disease persist 48 hours after the last injection, treatment should be changed using another formulation or another antibiotic and continued until clinical signs have resolved.

Note: Introflor-300 is not for use in cattle producing milk for human consumption.

CONTRAINDICATIONS:

Not for use in cattle producing milk for human consumption.

Not to be used in adult bulls or boars intended for breeding purposes.

Do not administer in cases of previous allergic reactions to florfenicol.

SIDE EFFECTS:

In cattle, a decrease in food consumption and transient softening of the faeces may occur during the treatment period. The treated animals recover quickly and completely upon termination of treatment. Administration of the product by the intramuscular and subcutaneous routes may cause inflammatory lesions at injection site which persist for 14 days.

In swine, commonly observed adverse effects are transient diarrhoea and/or peri-anal and rectal erythema/oedema which may affect 50% of the animals. These effects can be observed for one week. Transient swelling lasting up to 5 days may be observed at the site of injection. Inflammatory lesions at the injection site may be seen up to 28 days.

WITHDRAWAL TIMES:

- For meat :

Cattle: 30 days (IM route).

           : 44 days (SC route).

Swine: 18 days.

WARNING:

Keep out of reach of children.

Florfenicol 30% Injection

Product Categories : Animal Antibacterial Drugs > Florfenicol

Email to this supplier
  • *Subject:
  • *To:
    Mr. kenneth Yang
  • *Email:
  • *Message:
    Your message must be between 20-8000 characters

Home > Products > Animal Antibacterial Drugs > Florfenicol > Florfenicol Injection 30% Veterinary

Send Inquiry
*
*

Send Inquiry

kenneth Yang

Mr. kenneth Yang

Email:

Send Inquiry

Tel:86-311-80677112

Fax:86-311-80677113

Mobile Phone:+8618618225717Contact me with Whatsapp

Email:

Address:NO.114 High And New Technology Industrial Development Zone Luquan, Shijiazhuang, Hebei

Mobile Site

Home

Product

Whatsapp

About Us

Inquiry

We will contact you immediately

Fill in more information so that we can get in touch with you faster

Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.

Send